Using an AI system and breast density to quantify the short-term risk of interval cancer in a large screening cohort Alexander J.T. Wanders, MD1, Willem Mees, MD1, Natasja Janssen PhD2, Mehmet Ufuk Dalmis, PhD2, Alejandro Rodriguez-Ruiz, PhD2,Ioannis Sechopoulos, PhD3,4, Carla H. van Gils, PhD5, Nico Karssemeijer, PhD2,3, Ritse M. Mann, PhD MD3, Jan-Kees van Rooden, PhD MD1,6
1Bevolkingsonderzoek Zuid-West Borstkanker, Laan 20, 2512 GB, Den Haag, The Netherlands
2ScreenPoint Medical BV, Toernooiveld 300, 6525 EC, Nijmegen, The Netherlands
3Department of Medical Imaging, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, Geert Grooteplein 10, 6525 GA, Post 766, Nijmegen, The Netherlands
4Dutch Expert Centre for Screening (LRCB), Wijchenseweg 101, 6538 SW, Nijmegen, The Netherlands
5Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
6Department of Radiology, Haga Teaching Hospital, PO Box 40551, 2545 LN, The Hague, The Netherlands